Castle Biosciences Inc
CSTL- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001447362
In the last 90 days, Castle Biosciences Inc insiders filed 0 open-market purchases and 21 sales; 176 institutions reported holding it in 13F filings for Q2 2026, worth $653.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Castle Biosciences Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 148 | 130 | −18 |
| Shares | 22.1M | 23.0M | +876.4K (+4.0%) |
| Value | $501.9M | $316.6M | −$185.3M (−36.9%) |
New holders (16)
Institutions that held Castle Biosciences Inc at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 258,151 | $3.54M | 0.02% |
| Parkman Healthcare Partners LLC | 148,002 | $2.03M | 0.35% |
| Numerai GP LLC | 67,200 | $922.0K | 0.19% |
| Jane Street Group, LLC | 23,162 | $317.8K | 0.00% |
| DFPG Investments, LLC | 16,152 | $275.6K | 0.02% |
| Verition Fund Management LLC | 17,642 | $242.0K | 0.00% |
| Point72 Middle East FZE | 15,728 | $215.8K | 0.01% |
| Commonwealth Equity Services, LLC | 15,296 | $210.0K | 0.00% |
| Harbor Capital Advisors, Inc. | 14,264 | $195.7K | 0.04% |
| American Century Companies Inc | 13,430 | $184.3K | 0.00% |
| Channing Capital Management, LLC | 13,403 | $183.9K | 0.01% |
| Truist Financial Corp | 12,899 | $177.0K | 0.00% |
| Qube Research & Technologies Ltd | 12,699 | $174.2K | 0.00% |
| Russell Investments Group, Ltd. | 7,720 | $105.9K | 0.00% |
| BerganKDV Wealth Management, LLC | 525 | $7.20K | 0.00% |
| Bollard Group LLC | 139 | $2.00K | 0.00% |
Sold out (34)
Institutions that held Castle Biosciences Inc at the end of Q1 2023 and filed for Q2 2023 without it.